ACADEMIC AND RESEARCH PEER-REVIEWED MEDICAL JOURNALISSN 1727-2378 (Print)         ISSN 2713-2994 (Online)
Ru
En

Biochemical Markers of Hypoxic Brain Damage in Full-Term Newborns

DOI:0.31550/1727-2378-2020-19-3-12-16
Bibliography link: Panchenko A.S., Panova M.S. Biochemical Markers of Hypoxic Brain Damage in Full-Term Newborns. Doctor.Ru. 2020; 19(3): 12–16. (in Russian) DOI: 0.31550/1727-2378-2020-19-3-12-16
19 May 08:51

Study Objective: to assess biochemical markers of brain damage in full-term newborns who suffered from antenatal hypoxia and/or asphyxia at birth.

Study Design: retrospective cohort clinical study.

Materials and Methods. The study enrolled 142 full-term newborns divided into two groups: group 1 (study group) (n = 90) — children who suffered from antenatal hypoxia and/or asphyxia at birth; group 2 (controls) (n = 52) — children with Apgar score 8 and higher at birth who did not suffer from antenatal hypoxia. Neonatal records (gestation course and delivery, early neonatal period) were analysed retrospectively; the concentration of interleukins (IL-1β, IL-4, IL-6, IL-8) and neuro-specific enolase (NSE) in umbilical blood plasma was evaluated.

Study Results. The analysis of interleukins and NSE concentration identified statistically significant difference between groups. Markers in hypoxia episodes were significant raise in NSE levels — 9.63 (6.71; 14.94) and pro- and anti-inflammatory cytokines: IL-1β — 8.5 (0.09; 36.39), IL-6 — 14.11 (6.71; 141.0), IL-8 — 50.4 (10.8; 182.7), IL-4 — 0.90 (0.00; 3.84).

Conclusion. Central nervous system damages should be diagnosed using lab methods with evaluation of markers indicative of pathological process. Children with past antenatal hypoxia/ asphyxia demonstrate increased IL-1β, IL-6, IL-8, IL-4 and NSE levels; some children from the study group did not have any neurological symptoms and corresponding diagnosis.

Contribution: Panchenko, A.S. — thematic publications reviewing; study design; review of critically important material; approval of the manuscript for publication; Panova, M.S. — patients selection and evaluation; thematic publications reviewing; study design; review of critically important material; collection of clinical materials; data processing, analysis and interpretation; approval of the manuscript for publication.

Conflict of interest: The authors declare that they do not have any conflict of interests.

A.S. Panchenko (Corresponding author) — Chita State Medical Academy of the Ministry of Health of the Russian Federation; 39A Gorky Str., Chita, Russian Federation 672000. eLIBRARY.RU SPIN: 9552-2350. E-mail: sashawomen@mail.ru

M.S. Panova — Chita State Medical Academy of the Ministry of Health of the Russian Federation; 39A Gorky Str., Chita, Russian Federation 672000. eLIBRARY.RU SPIN: 3461-5321. E-mail: merik2002@mail.ru

Доктор.ру

Table
Interleukin (IL) concentration in umbilical blood plasma in newborns from the study group and control group, IU (25; 75)

t2_1.jpg

Received: 29.01.2020
Accepted: 18.02.2020

19 May 08:51
LITERATURE
  1. Eremina O.V., Dolgushina N.V., Baev O.R. Clinical and economic efficiency of direct electrocardiography with st-analysis in assessing the condition of the fetus. Obstetrics and Gynecology. 2016; 4: 49–55. (in Russian). DOI: 10.18565/aig.2016.4.49-55
  2. Kuznecov P.A., Kozlov P.V. Fetal hypoxia and asphyxia of the newborn. Therapy. 2017; 4: 9–15. (in Russian)
  3. Shabalov N.P. Neonatology. M.: GEOTAR-Media; 2016. 704 р. (in Russian)
  4. Placha K., Luptakova D., Baciak L., Ujhazy E., Juranek I. Neonatalbrain injury as a consequence of insufficient cerebral oxygenation. Neuro Endocrinol. Lett. 2016; 37(2): 79–96.
  5. Classification of perinatal lesions of the nervous system in newborns. Methodological recommendations. M.: ARESMC; 2000. 40 p. (in Russian)
  6. Murray K.N., Parry-Jones A.R., Allan S.M. Interleukin-1 and acute brain injury. Front. Cell Neurosci. 2015; 9: 18. DOI: 10.3389/fncel.2015.00018
  7. Chaparro-Huerta V., Flores-Soto M.E., MerinSigala M.E., Barrera de León J.C., Lemus-Varela M.L., Torres-Mendoza B.M. et al. Proinflammatory cytokines, enolase and S-100 as early biochemical indicators of hypoxic-ischemic encephalopathy following perinatal asphyxia in newborns. Pediatr. Neonatol. 2017; 58(1): 70–6. DOI: 10.1016/j.pedneo.2016.05.001
  8. Massaro A.N., Wu Y.W., Bammler T.K., Comstock B., Mathur A., McKinstry R.C. et al. Plasma biomarkers of brain injury in neonatal hypoxic-ischemic encephalopathy. J. Pediatr. 2018; 194: 67–75.e1. DOI: 10.1016/j.jpeds.2017.10.060
  9. Doll D.N., Barr T.L., Simpkins J.W. Cytokines: their role in stroke and potential use as biomarkers and therapeutic targets. Aging Dis. 2014; 5(5): 294–306. DOI: 10.14336/AD.2014.0500294
  10. Vedunova M.V., Terent'yeva K.A., Shchelchkova N.A., Kosareva M.A., Mishchenko T.A., Khaletskaya O.V. et al. The diagnostic value of determining the concentration of neurotrophic factors and neuron-specific enolase in the blood of newborns with central nervous system disorders. STM. 2015; 7(2): 25–32. (in Russian). DOI: 10.17691/stm2015.7.2.03
  11. Morgun A.V., Ovcharenko N.V., Taranushenko T.E., Ustinova S.I., Okuneva O.S., Antonova S.K. Markers of apoptosis and neurospecific proteins in the diagnosis of perinatal lesions of the central nervous system in newborns. Siberian Medical Review. 2013; 3: 3–11. (in Russian)
  12. Baybarina E.N., ed. Methodical letter "Resuscitation and stabilization of newborns in the delivery room": approved and put into effect by Order of the Deputy Minister of health of the Russian Federation from 04.03.2020 N 15-4/I/2-2570. M.; 2020. 64 p. (in Russian)
  13. Palchik A.B., Shabalov N.P. Hypoxic-ischemic encephalopathy of the newborn. M.: MedPress-Inform; 2013. 288 p. (in Russian)
  14. Declaration of Helsinki — Ethical Principles for Medical Research Involving Human Subjects. World Health Organization. 2018. URL: www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/ (access date: 20.04.2020).
  15. Riljak V., Kraf J., Daryanani A., Jiruškaj P., Otáhal J. Pathophysiology of perinatal hypoxic-ischemic encephalopathy — biomarkers, animal models and treatment perspectives. Physiol. Res. 2016; 65(suppl.5): S533–45. DOI: 10.33549/physiolres.933541
  16. Iutinskij E.M., Dvoryanskij S.A., Drozhdina M.B. The course of pregnancy and childbirth in women with fetoplacental insufficiency. Scientific statements. Series “Medicine. Pharmacy”. 2014; 18(189): 54–7. (in Russian)
  17. Perlman D.M. Neurology: neonatology questions and controversies. M.: Logosphera; 2015. 392 p. (in Russian)
  18. Simbircev A.S. Cytokines in the pathogenesis and treatment of human diseases. SPb.: Foliant; 2018. 512 p. (in Russian)
  19. Chistyakova G.N., Remizova L.L., Gazieva L.A., Bychkova S.V., Zanina E.V., Charipova B.T. Pro- and anti-inflammatory mediators in neonates with perinatal pathology. Russian Journal of Perinatology and Pediatrics. 2014; 59(2): 66–70. (in Russian)
  20. Yаkornova G.V., Remizova I.I., Chistiakova G.N., Ustieiantseva L.S. Time course of changes in proinflammatory cytokines in infants born to women with complicated pregnancy in relation to the course of an early adaptation period. Russian Journal of Perinatology and Pediatrics. 2015; 60(4): 50–6. (in Russian)
  21. Mazarico E., Llurba E., Cabero L., Sánchez O., Valls A., Martín-Ancel A. et al. Associations between neural injury markers of intrauterine growth-restricted infants and neurodevelopment at 2 years of age. J. Matern. Fetal Neonatal Med. 2019; 32(19): 3197–203. DOI: 10.1080/14767058.2018.1460347
Новости мировой медицины! Свежие статьи из журнала! Будьте в курсе!

Похожие статьи

Similar article
19 April 00:00, Interview
Interview
Doctor.Ru Pediatrics. Vol. 20, No. 3 (2021)
19 April 00:00, Paediatrics
A.V. Aksenov, E.A. Ivanovskaya
Successful Use of Tocilizumab in a Child with Systemic Juvenile Idiopathic Arthritis
Doctor.Ru Pediatrics. Vol. 20, No. 3 (2021)

News